Life Sciences > HRA logo

HRA Pharma

 

Establishing a strong position in category leadership and pipeline innovation Highlights

•A shift in perception, from product pioneers to an established corporation and a genuine European market contender

• Coverage in key titles such as: Scrip, The Pink Sheet, Fierce Pharma, Pharmaceutical Executive, Le Monde, The New York Times, Wall Street Journal and Reuters

• Recognition across a swathe of influential industry awards programs

Where we started

Founded in 1996, HRA Pharma was already established as a pioneer in emergency contraception, being the first to launch a single progesterone pill in 1998. With regulatory approvals underway for a next generation emergency contraceptive, this major milestone marked the start of an invigorated PR approach. A strong R&D pipeline and a Europe-wide corporate focus would be the cornerstones of this approach, with clear objectives for overall growth and more dominant market positioning.

What we advised

We saw that the timing was right for HRA Pharma to be positioned as the de facto emerging leader in reproductive health. We advised clear and consistent messaging, with a focus on HRA’s R&D pipeline, European infrastructure and impressive growth.

What we did

A sustainable PR approach: We overhauled the existing and sporadic PR approach to become consistent, proactive and future-facing. Regular announcements and a steady flow of relevant content underpinned this

Relationship building: Ballou PR placed heavy emphasis on building relationships between HRA spokespeople and key target media. Briefings and interviews provided an opportunity for heightened corporate awareness, greater sector understanding and kept HRA top-of-mind

Awards and events: We developed a robust awards approach for HRA, identifying the most relevant awards programs, crafting compelling submissions and driving media relations alongside it

What we achieved for HRA Pharma

 

  • A sustainable and solid PR approach, which sets the organization in good stead for the future
  • An awards submission program was established, with recognition for excellence in a number of categories Heightened profiles for key representatives of HRA Pharma, further positioning the organization as a leading pharma player